MEACOR
Pioneering transcatheter solutions for advanced heart disease treatment.
United States
3 employees
Series A
Total: $15.00M
Health Care, Medical Devices
General Information
United States
BounceWatch is an independent company data service, not affiliated with MEACOR. To contact MEACOR, visit meacor.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MEACOR compare?
A PDF of MEACOR and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MEACOR soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Health Care
About MEACOR
Business keywords: transcatheter interventions, heart disease treatment, valvular disease, minimally invasive, cardiology innovation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $15.00M | - |
|
14 May 2024 |
| Non Equity Assistance | Undisclosed | 1 |
|
07 Jun 2022 |
MEACOR Alternatives & Competitors
View All Alternatives
Pioneering minimally invasive mitral valve repair solutions for effective heart disease treatment
Presenting the ModulHeart. Low-risk heart support for patients with advanced heart failure
FAQ About MEACOR
Source: BounceWatch company record for MEACOR, https://bouncewatch.com/company/meacor, updated 25 October 2024. When citing, please name BounceWatch and link this page.
